Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial
LIR! C trial showed laparoscopic ileocaecal resection is a cost-effective treatment for Crohn's disease. It has similar quality-of-life outcomes to treatment with infliximab, an anti-tumor necrosis factor drug.

Related Post